Sun Pharmaceutical Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Sun Pharmaceutical Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sun Pharmaceutical Industries Limited has informed the Exchange about Credit Rating
Sun Pharmaceutical Industries Limited has informed the Exchange about Resignation of Director/KMP/SMP
Outcome of the Board Meeting held on 12 October 2026
Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
Newspaper Publication about Postal Ballot/E-voting October 2026
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2026, titled "New LEQSELVI® (deuruxolitinib) Two-YearData in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026".